Compound: mitomycin C
SMILES: O=C1C(=C(N)C(=O)C2=C1N3[C@](OC)([C@H]4N[C@H]4C3)[C@@H]2COC(=O)N)C
InChIKey: NWIBSHFKIJFRCO-WUDYKRTCSA-N
Synonyms: mitomycin C, Mitomycin, 50-07-7, Ametycine, Mutamycin, Mitomycin-C, Mitocin-C, Ametycin, Mitomycinum, Mytomycin, Mytozytrex, Mitomycinum C, Mitocin C, Mitamycin, Mitosol, NSC-26980, Muamycin, Mitomycyna C, 7-Amino-9alpha-methoxymitosane, Mito-C, Mitomicina, Mitomycine, NCI-C04706, NSC26980, NSC 26980, DTXSID2020898, JELMYTO, UGN-101, UGN-102, 50SG953SK6, DTXCID00898, CHEBI:27504, (1aS,8S,8aR,8bS)-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, [(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate, [(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0^{2,7}.0^{4,6}]trideca-1(9),11-dien-8-yl]methyl carbamate, Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methyl-, carbamate (ester), Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-, Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-, MitocinC, Mutamycine, Mitocin, Mitolem, Mitomycine C, Mito-Medac, Mitomycin-X, ((4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo(7.4.0.0^(2,7).0^(4,6))trideca-1(9),11-dien-8-yl)methyl carbamate, ((4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo(7.4.0.02,7.04,6)trideca-1(9),11-dien-8-yl)methyl carbamate, (1as,8s,8ar,8bs)-6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, RefChem:55655, CHEBI:25357, DTXSID00858942, L01DC03, (1aS,8S,8aR,8bS)-6-Amino-4,7-dioxo-8a-methoxy-5-methyl-1,1a,2,8,8a,8b-hexahydroazirino(2',3':3,4)pyrrolo(1,2-a)indol-8-ylmethyl carbamate, (1aS-(1a alpha,8beta,8a alpha,8b alpha))-6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 200-008-6, Mitozytrex, MMC, Mit-C, RCRA waste number U010, Mitomycyna C [Polish], MFCD00078109, 6-Amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester), 1404-00-8, CAS-50-07-7, Muamycin (TN), ((1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl carbamate, [(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate, [(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate, CCRIS 414, HSDB 3239, Mitomycin (USP/INN), MLS002702984, (amino-methoxy-methyl-dioxo-[?]yl)methyl carbamate, EINECS 200-008-6, RCRA waste no. U010, 7-Amino-9.alpha.-methoxymitosane, UNII-50SG953SK6, AI3-26199, Mitomycin CRS, Mitomycin [USAN:USP:INN:BAN], NCGC00095258-01, Mitomycin; [(1aS,8S,8aR,8bS)-6-Amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2'',3'':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate; Mitomycin C, Jelmyto (TN), ZUSDURI, Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))-, Mitomycin C from Streptomyces caespitosus, MITOMYCIN [INN], Mitomycin C (JP18), MITOMYCIN [HSDB], MITOMYCIN [USAN], MITOMYCIN [VANDF], MITOMYCIN C [MI], CHEMBL105, MITOMYCIN [MART.], MITOMYCIN C [JAN], MITOMYCIN [USP-RS], MITOMYCIN [WHO-DD], Mitomycin C - High Purity, MITOMYCIN C [IARC], SCHEMBL3760, CBiol_001927, BSPBio_001267, KBioGR_000607, KBioSS_000607, Mitomycin C (4% in NaCl), MLS001332654, orb422198, Mitozytrex (TN) (Supergene), 50-07-7 (non-salt), GTPL7089, orb3027145, MITOMYCIN [ORANGE BOOK], MITOMYCIN [EP MONOGRAPH], KBio2_000607, KBio2_003175, KBio2_005743, KBio3_001073, KBio3_001074, EX-A501, MITOMYCIN [USP MONOGRAPH], Mitomycin C - Bio-X trade mark, Bio1_000213, Bio1_000702, Bio1_001191, Bio2_000464, Bio2_000944, HMS1362O09, HMS1792O09, HMS1990O09, HMS2089F16, HMS3403O09, AZIRINO(2',3':3,4)PYRROLO(1,2-A)INDOLE-4,7-DIONE, 6-AMINO-8-(((AMINOCARBONYL)OXY)METHYL)-1,1A,2,8,8A,8B-HEXAHYDRO-8A-METHOXY-5-METHYL-, (1AS-(1A.ALPHA.,8.BETA.,8A.ALPHA.,8B.ALPHA.))-, Tox21_111493, AC-918, BDBM50428658, EBC-26628, GR-311, HB4458, s8146, AKOS015895703, Tox21_111493_1, AM26019, CCG-208564, CS-0564, DB00305, KS-5148, IDI1_002219, SMP1_000307, Mitomycin 100 microg/mL in Acetonitrile, NCGC00163468-02, NCGC00163468-03, NCGC00163468-05, NCGC00163468-06, AM161650, BM164668, HY-13316, SMR000058401, M2320, NS00004729, C06681, D00208, D91590, AB00918689-03, AB00918689-04, EN300-7405455, BRD-K59670716-001-02-6, BRD-K59670716-001-06-7, Q19856779, WLN: T D3 B556 BN EM JV MVTTT&J GO1 H1OVZ KZ L1, Mitomycin C from Streptomyces caespitosus, >=970 mug/mg (USP XXIV), Mitomycin C from Streptomyces caespitosus, powder, BioReagent, suitable for cell culture, Mitomycin C from Streptomyces caespitosus, powder, contains NaCl as solubilizer, Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a- methoxy-5-methyl-, carbamate (ester), Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b- hexahydro-8a-methoxy-5-methyl-, [1aR-(1a.alpha.,8.beta.,8a.alpha.,8b.alpha.)]-, Mitomycin C from Streptomyces caespitosus, >=98% (HPLC), potency: >=970 mug per mg (USP XXIV), gamma-irradiated, suitable for cell culture
Theoretical properties:
molecular_formula: C15H18N4O5
molecular_weight: 334.33 g/mol
exact_mass: 334.12771969 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 3
hydrogen_bond_acceptor_count: 8
rotatable_bond_count: 4
heavy_atom_count: 24
topological_polar_surface_area: 147 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
physical_state: BLUE-VIOLET CRYSTALS
color: BLUE-VIOLET CRYSTALS
melting_point: Above 680 °F (EPA, 1998)
solubility: Soluble (NTP, 1992)
Descriptions:
pubchem: Mitomycin C can cause cancer according to an independent committee of scientific and health experts.
chembl: MITOMYCIN is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Mitomycin C is a mitomycin that is used as a chemotherapeutic agent by virtue of its antitumour activity.